Table 3.
Baseline Hemodynamic parameters and Echocardiographic findings.
| Subjects | n (%) |
|---|---|
| RHC | 98 (100) |
| mRAP, mmHg | 8.0 (5.0) |
| mPAP, mmHg | 44.5 (15.3) |
| PAWP, mmHg | 10.0 (4.5) |
| CO, L/min | 4.3 (1.5) |
| CI, L/min/m2 | 2.4 (1.0) |
| PVR, WU | 7.4 (4.8) |
| HR, bpm | 78.0 (14.3) |
| SVO2, % | 67.0 (14.0) |
| Echocardiography | 61 (62.2) |
| RV hypertrophy | 23 (23.5) |
| RVEDD, mm | 33.2 ± 12.5 |
| TAPSE, mm | 18.5 ± 4.7 |
| TR Vmax, m/s | 3.9 ± 0.7 |
| RVSP, mmHg | 74.0 ± 22.5 |
Categorical variables are presented as frequency and percentage, n (%). Continuous variables are presented as mean value ± standard deviation or median value with interquartile range. n: the absolute count of variables measured in the overall population; RHC: Right heart catheterization; mRAP: mean Right Atrial Pressure; mPAP: mean Pulmonary Artery Pressure; PAWP: Pulmonary Artery Wedge Pressure; CO: Cardiac Output; CI: Cardiac Index; PVR: Pulmonary Vascular Resistance; WU: Wood Units; HR: Heart Rate; bpm: beats per minute; SvO2; oxygen saturation in pulmonary artery; RV: Right Ventricle; RVEDD: Right Ventricular End-Diastolic Diameter; TAPSE: Tricuspid Annular Plane Systolic Excursion; TR Vmax: maximal velocity of tricuspid regurgitation; RVSP: Right Ventricular Systolic Pressure.